A detailed history of Knightsbridge Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Knightsbridge Asset Management, LLC holds 3,394 shares of NVS stock, worth $349,887. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,394
Previous 3,154 7.61%
Holding current value
$349,887
Previous $335,000 16.42%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $25,471 - $29,013
240 Added 7.61%
3,394 $390,000
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $66,002 - $76,554
713 Added 29.21%
3,154 $335,000
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $225,231 - $247,859
2,441 New
2,441 $246,000
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $5,121 - $5,939
-64 Reduced 2.37%
2,636 $243,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $203,985 - $249,804
2,700 New
2,700 $245,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Knightsbridge Asset Management, LLC Portfolio

Follow Knightsbridge Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knightsbridge Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knightsbridge Asset Management, LLC with notifications on news.